Cellectar Biosciences (CLRB) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free CLRB Stock Alerts $3.09 +0.05 (+1.64%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Cellectar Biosciences Short Interest DataCurrent Short Interest2,270,000 sharesPrevious Short Interest2,550,000 sharesChange Vs. Previous Month-10.98%Dollar Volume Sold Short$7.63 millionShort Interest Ratio2.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares35,850,000 sharesFloat Size34,690,000 sharesShort Percent of Float6.54%Today's Trading Volume255,515 sharesAverage Trading Volume505,167 sharesToday's Volume Vs. Average51% Short Selling Cellectar Biosciences ? Sign up to receive the latest short interest report for Cellectar Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLRB Short Interest Over TimeCLRB Days to Cover Over TimeCLRB Percentage of Float Shorted Over Time Ad Behind the MarketsLEAKED: Jeff Bezos' $330 Million GambleDid you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough.Here's how you could invest alongside them >>> Cellectar Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,270,000 shares $7.63 million -11.0%6.5%2.4 $3.36 4/30/20242,550,000 shares $7.88 million +16.4%7.9%2.7 $3.09 4/15/20242,190,000 shares $7.27 million -13.4%7.5%2 $3.32 3/31/20242,530,000 shares $10.07 million +34.6%8.7%1.4 $3.98 3/15/20241,880,000 shares $6.54 million -6.5%16.9%1.1 $3.48 2/29/20242,010,000 shares $7.88 million -15.2%17.0%1.2 $3.92 Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20242,370,000 shares $8.51 million +25.4%20.1%1.6 $3.59 1/31/20241,890,000 shares $7.39 million +13.2%17.2%1.4 $3.91 1/15/20241,670,000 shares $5.86 million +208.6%15.2%1.5 $3.51 12/31/2023541,100 shares $1.50 million -9.8%4.9%0.6 $2.77 12/15/2023599,900 shares $1.59 million -11.4%5.5%3.2 $2.65 11/30/2023676,700 shares $1.67 million -15.4%6.7%3.9 $2.47 11/15/2023800,100 shares $1.58 million -7.2%6.9%1.1 $1.98 10/31/2023861,800 shares $2.09 million +3.2%9.2%1.3 $2.42 10/15/2023835,300 shares $2.16 million +25.8%8.9%1.3 $2.59 9/30/2023664,100 shares $1.75 million +37.7%7.1%1 $2.64 9/15/2023482,200 shares $1.07 million +238.4%5.2%0.8 $2.21 8/31/2023142,500 shares $252,225.00 -1.8%1.6%0.2 $1.77 8/15/2023145,100 shares $248,121.00 -9.3%1.6%5.7 $1.71 7/31/2023159,900 shares $311,805.00 +15.0%1.7%4.8 $1.95 7/15/2023139,100 shares $255,944.00 +8.9%1.5%3.7 $1.84 6/30/2023127,700 shares $249,015.00 +18.5%1.4%3.3 $1.95 6/15/2023107,800 shares $220,990.00 +29.4%1.2%2.7 $2.05 5/31/202383,300 shares $129,948.00 +2.7%0.9%2.2 $1.56 5/15/202381,100 shares $111,918.00 -7.4%0.9%1.4 $1.38 4/30/202387,600 shares $134,904.00 +25.5%1.0%1.4 $1.54 4/15/202369,800 shares $97,720.00 +47.3%0.8%1.2 $1.40 3/31/202347,400 shares $67,782.00 +4.2%0.5%0.8 $1.43 3/15/202345,500 shares $69,160.00 +237.0%0.5%0.7 $1.52 2/28/202313,500 shares $21,060.00 -49.6%0.2%0.2 $1.56 2/15/202326,800 shares $44,656.84 +8.1%0.3%0.5 $1.67 1/31/202324,800 shares $37,448.00 -40.0%0.3%0.5 $1.51 1/15/202341,300 shares $70,416.50 +50.7%0.5%0.7 $1.71 12/30/202227,400 shares $46,854.00 +144.6%0.3%0.5 $1.71 12/15/202211,200 shares $15,344.00 -9.7%0.1%0.2 $1.37 11/30/202212,400 shares $23,312.00 +53.1%0.1%0.3 $1.88 11/15/20228,100 shares $15,309.00 -16.5%0.1%0.2 $1.89 10/31/20229,700 shares $19,594.00 +61.7%0.1%0.3 $2.02 10/15/20226,000 shares $12,540.00 -1.6%0.1%0.2 $2.09 9/30/20226,100 shares $20,496.00 -28.2%0.1%0.2 $3.36Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 9/15/20228,500 shares $40,460.00 +6.3%0.2%0.4 $4.76 8/31/20228,000 shares $43,872.00 -64.8%0.1%0.3 $5.48 8/15/202222,700 shares $141,875.00 +59.9%0.4%0.9 $6.25 7/31/202214,200 shares $55,664.00 +647.4%0.3%0.6 $3.92 7/15/20221,900 shares $8,168.08 +111.1%N/A0.1 $4.30 6/30/20229,200 shares $3,716.80 -55.3%0.2%0.1 $0.40 6/15/202220,600 shares $7,698.22 -61.5%0.4%0.1 $0.37 5/31/202253,500 shares $21,935.00 +2.9%N/A0.3 $0.41 5/15/202252,000 shares $19,760.00 +112.2%N/A0.3 $0.38 4/30/202224,500 shares $13,107.50 -55.7%N/A0.1 $0.54 4/15/202255,300 shares $38,079.58 -74.2%N/A0.3 $0.69 3/31/2022214,700 shares $147,670.66 +70.1%N/A1.1 $0.69 3/15/2022126,200 shares $59,440.20 +10.8%N/A0.5 $0.47 2/28/2022113,900 shares $58,145.95 -43.1%N/A0.4 $0.51 2/15/2022200,100 shares $110,455.20 -14.4%N/A0.6 $0.55 1/31/2022233,800 shares $140,280.00 +283.9%N/A0.7 $0.60 1/15/202260,900 shares $42,563.01 +138.8%N/A0.2 $0.70 12/31/202125,500 shares $16,932.00 -74.6%N/A0.1 $0.66 12/15/2021100,500 shares $68,048.55 -32.7%N/A0.3 $0.68 11/30/2021149,300 shares $103,166.30 +112.1%N/A0.4 $0.69 11/15/202170,400 shares $59,368.32 -27.9%N/A0.2 $0.84 10/29/202197,700 shares $84,217.40 -38.4%N/A0.2 $0.86 10/15/2021158,700 shares $145,543.77 -85.2%N/A0.3 $0.92 9/30/20211,070,000 shares $989,750.00 +2.9%N/A1.4 $0.93 9/15/20211,040,000 shares $1.02 million -4.6%N/A1.2 $0.98 8/31/20211,090,000 shares $1.11 million -16.2%N/A1.1 $1.02 8/13/20211,300,000 shares $1.13 million -13.3%N/A1.3 $0.87 7/30/20211,500,000 shares $1.64 million -5.7%3.2%1.8 $1.09 7/15/20211,590,000 shares $1.67 million +40.7%3.4%2.1 $1.05 6/30/20211,130,000 shares $1.34 million -26.1%2.4%1.6 $1.19 6/15/20211,530,000 shares $2.00 million -12.1%3.2%2.6 $1.31 5/28/20211,740,000 shares $2.85 million +4.8%3.7%2.5 $1.64 5/14/20211,660,000 shares $2.08 million -11.7%N/A1.9 $1.25 4/30/20211,880,000 shares $2.91 million +2.2%N/A1.4 $1.55 4/15/20211,840,000 shares $2.74 million -13.2%N/A1.1 $1.49 3/31/20212,120,000 shares $3.26 million -1.4%N/A1.1 $1.54 3/15/20212,150,000 shares $4.19 million -9.3%N/A0.9 $1.95 2/26/20212,370,000 shares $4.67 million +2.6%N/A0.9 $1.97 2/12/20212,310,000 shares $5.73 million +4.1%N/A0.8 $2.48 1/29/20212,220,000 shares $3.95 million -1.3%N/A0.9 $1.78 1/15/20212,250,000 shares $4.61 million -11.1%N/A1.1 $2.05 12/31/20202,530,000 shares $5.44 million -4.2%N/A1.4 $2.15 12/15/20202,640,000 shares $5.46 million +161.4%N/A1.7 $2.07 11/30/20201,010,000 shares $1.24 million -3.8%N/A1.1 $1.23 11/15/20201,050,000 shares $1.19 million -2.8%N/A3.9 $1.13 10/30/20201,080,000 shares $1.29 million +4.9%N/A2.8 $1.19 10/15/20201,030,000 shares $1.30 million -1.0%N/A1.6 $1.26 9/30/20201,040,000 shares $1.29 million +1.0%N/A1.4 $1.24 9/15/20201,030,000 shares $1.28 million -8.0%N/A1.2 $1.24 8/31/20201,120,000 shares $1.33 million +6.7%N/A1.2 $1.19Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 8/14/20201,050,000 shares $1.50 million -6.3%N/A0.8 $1.43 7/31/20201,120,000 shares $1.69 million +284.2%N/A1 $1.51 7/15/2020291,500 shares $411,015.00 +213.4%N/A0.3 $1.41 6/30/202093,000 shares $120,900.00 +54.7%N/A0.1 $1.30 6/15/202060,100 shares $70,918.00 -94.1%N/A0.1 $1.18 5/29/20201,010,000 shares $1.53 million +1,681.3%N/A2 $1.51 5/15/202056,700 shares $82,215.00 +6,200.0%0.7%0.4 $1.45 4/30/2020900 shares $1,535.40 -76.3%0.0%0 $1.71 4/15/20203,800 shares $6,213.76 -92.9%0.0%0 $1.64 3/31/202053,300 shares $77,818.00 -86.3%0.6%0.3 $1.46 3/13/2020388,100 shares $539,459.00 -9.2%4.3%4.9 $1.39 2/28/2020427,200 shares $508,368.00 +13.3%4.8%2.5 $1.19 2/14/2020377,100 shares $757,971.00 +6.3%4.2%2.2 $2.01 1/31/2020354,900 shares $798,525.00 +13.8%4.0%2.9 $2.25 1/15/2020311,900 shares $842,130.00 +88.9%3.4%2.5 $2.70 12/31/2019165,100 shares $432,562.00 -30.4%1.8%1.3 $2.62 8/15/2019403,300 shares $863,062.00 -5.3%8.7%0.9 $2.14 CLRB Short Interest - Frequently Asked Questions What is Cellectar Biosciences' current short interest? Short interest is the volume of Cellectar Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 2,270,000 shares of CLRB short. 6.54% of Cellectar Biosciences' shares are currently sold short. Learn More on Cellectar Biosciences' current short interest. What is a good short interest ratio for Cellectar Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLRB shares currently have a short interest ratio of 2.0. Learn More on Cellectar Biosciences's short interest ratio. Which institutional investors are shorting Cellectar Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cellectar Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cellectar Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.54% of Cellectar Biosciences' floating shares are currently sold short. Is Cellectar Biosciences' short interest increasing or decreasing? Cellectar Biosciences saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 2,270,000 shares, a decline of 11.0% from the previous total of 2,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cellectar Biosciences' float size? Cellectar Biosciences currently has issued a total of 35,850,000 shares. Some of Cellectar Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellectar Biosciences currently has a public float of 34,690,000 shares. How does Cellectar Biosciences' short interest compare to its competitors? 6.54% of Cellectar Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cellectar Biosciences: Biomea Fusion, Inc. (47.23%), Lexicon Pharmaceuticals, Inc. (9.45%), Neurogene Inc. (8.58%), Theravance Biopharma, Inc. (13.37%), Terns Pharmaceuticals, Inc. (5.19%), Acelyrin, Inc. (11.18%), Esperion Therapeutics, Inc. (16.09%), AC Immune SA (2.79%), Adlai Nortye Ltd. (0.03%), Ventyx Biosciences, Inc. (16.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Cellectar Biosciences stock? Short selling CLRB is an investing strategy that aims to generate trading profit from Cellectar Biosciences as its price is falling. CLRB shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectar Biosciences? A short squeeze for Cellectar Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLRB, which in turn drives the price of the stock up even further. How often is Cellectar Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLRB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Biomea Fusion Short Interest Lexicon Pharmaceuticals Short Interest Neurogene Short Interest Theravance Biopharma Short Interest Terns Pharmaceuticals Short Interest Acelyrin Short Interest Esperion Therapeutics Short Interest AC Immune Short Interest Adlai Nortye Short Interest Ventyx Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLRB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
